We are live on
!
Find out more
SLG
Stanley-Laman Group Portfolio holdings
AUM
$814M
1-Year Est. Return
40.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$256M
AUM Growth
-$276M
(-52%)
Cap. Flow
-$280M
Cap. Flow
% of AUM
-109.6%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
386
New
95
Increased
35
Reduced
90
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$1.3M |
| 2 |
Amphenol
APH
|
+$1.28M |
| 3 |
Kroger
KR
|
+$1.28M |
| 4 |
BCR
CR Bard Inc.
BCR
|
+$1.23M |
| 5 |
Toro Company
TTC
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$63.1M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$62.9M |
| 3 |
Huntsman Corp
HUN
|
+$7.52M |
| 4 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$7.03M |
| 5 |
GOV
Government Properties Income Trust
GOV
|
+$6.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 12.74% |
| 2 | Healthcare | 10.68% |
| 3 | Financials | 10.61% |
| 4 | Technology | 9.17% |
| 5 | Consumer Discretionary | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Macy's
M
$6.14B
| $812K | 0.32% |
+24,169
| New | +$865K |
|
127
Incyte
INCY
$23.3B
| $804K | 0.31% |
+10,050
| New | +$780K |
|
128
CVS Health
CVS
$136B
| $785K | 0.31% |
8,195
+1,937
| +31% | +$193K |
|
129
Rayonier
RYN
$6.41B
| $771K | 0.3% |
+32,389
| New | +$743K |
|
|
PACW
130
DELISTED
PacWest Bancorp
PACW
| $747K | 0.29% |
18,774
-158,657
| -89% | -$6.22M |
|
|
ISIL
131
DELISTED
Intersil Corp
ISIL
| $744K | 0.29% |
+54,979
| New | +$715K |
|
132
Cogent Communications
CCOI
$646M
| $743K | 0.29% |
+18,541
| New | +$728K |
|
|
UMPQ
133
DELISTED
Umpqua Holdings Corp
UMPQ
| $740K | 0.29% |
+47,854
| New | +$747K |
|
|
DNY
134
DELISTED
DONNELLEY R R & SONS CO
DNY
| $730K | 0.29% |
+43,136
| New | +$730K |
|
135
Home Depot
HD
$324B
| $727K | 0.28% |
5,690
+32
| +0.6% | +$4.23K |
|
136
Regeneron Pharmaceuticals
REGN
$68.3B
| $727K | 0.28% |
+2,082
| New | +$802K |
|
137
Bath & Body Works
BBWI
$3.9B
| $726K | 0.28% |
+13,379
| New | +$784K |
|
138
International Paper
IP
$20.1B
| $715K | 0.28% |
+17,820
| New | +$708K |
|
139
Travelers Companies
TRV
$78.5B
| $714K | 0.28% |
6,001
| – | – |
|
|
CVA
140
DELISTED
Covanta Holding Corporation
CVA
| $693K | 0.27% |
42,136
-20,270
| -32% | -$335K |
|
|
VIAB
141
DELISTED
Viacom Inc. Class B
VIAB
| $677K | 0.26% |
16,324
-150,246
| -90% | -$6.21M |
|
|
SRG
142
Seritage Growth Properties
SRG
$130M
| $628K | 0.25% |
12,610
-2,500
| -17% | -$125K |
|
143
Las Vegas Sands
LVS
$30.5B
| $623K | 0.24% |
+14,329
| New | +$669K |
|
|
TCP
144
DELISTED
TC Pipelines LP
TCP
| $615K | 0.24% |
+10,749
| New | +$583K |
|
145
ConocoPhillips
COP
$146B
| $611K | 0.24% |
14,007
-9,195
| -40% | -$406K |
|
146
B&G Foods
BGS
$285M
| $610K | 0.24% |
+12,648
| New | +$516K |
|
147
Amgen
AMGN
$201B
| $609K | 0.24% |
4,001
-1,428
| -26% | -$222K |
|
148
Colgate-Palmolive
CL
$72.1B
| $602K | 0.24% |
8,230
| – | – |
|
149
Northern Trust
NTRS
$21.9B
| $596K | 0.23% |
9,000
+2,000
| +29% | +$139K |
|
150
Plains All American Pipeline
PAA
$17.4B
| $593K | 0.23% |
+21,565
| New | +$522K |
|
Similar funds
VFG
KCP
AR
CICI
UAG
PS
BC
RPAM
Stanley-Laman Group's Q2 2016 Portfolio in Review
As of Q2 2016, Stanley-Laman Group held 386 positions worth $256M, down 52% from $532M the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Stanley-Laman Group withdrew a net $280M in Q2 2016, closing 128 positions and reducing 90 holdings. Its most notable exit was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $63.1M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 7.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Stanley-Laman Group opened a new position in Elevance Health worth $1.25M.
- Stanley-Laman Group's largest Q2 2016 buy was Elevance Health: 9,521 shares worth $1.25M.
- Stanley-Laman Group added most to Dollar Tree in Q2 2016, an estimated $1.13M increase.
- Stanley-Laman Group's biggest Q2 2016 reduction was Huntsman Corp, cutting an estimated $7.52M.
- Stanley-Laman Group fully exited State Street SPDR Bloomberg High Yield Bond ETF in Q2 2016, selling an estimated $63.1M.
- Stanley-Laman Group's ten largest holdings make up 21% of its $256M portfolio in Q2 2016.
- Stanley-Laman Group opened 95 new positions and closed 128 in Q2 2016.
- Stanley-Laman Group's portfolio value fell 52% quarter-over-quarter to $256M.
Based on Stanley-Laman Group's 13F filing for Q2 2016, filed 4 Aug 2016.